Pathozone 25 mg/ml Suspensie voor intramammair gebruik
Pathozone 25 mg/ml Suspensie voor intramammair gebruik
Authorised
- Cefoperazone sodium
Product identification
Medicine name:
Pathozone 25 mg/ml Suspensie voor intramammair gebruik
Pathozone 25 mg/ml Suspension intramammaire
Pathozone 25 mg/ml Suspension zur intramammären Anwendung
Active substance:
- Cefoperazone sodium
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefoperazone sodium259.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (lactating cow)
-
Meat and offal2day
-
Milk96hour8 milkings
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DD12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Pathozone 10 ml Syringe Intramammary suspension
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V134556
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
